Unicycive Therapeutics logo

Unicycive Therapeutics

UNCY | NASDAQ
Chart Builder DCF Calculator
$3.70
+$0.15 (+4.23%)
At close: Nov 16, 2026, 4:00 PM ET
$3.70
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:34 PM ET
+4.23%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #617/1021 (Top 60%)

Key Statistics

Market Data

Market Cap $101.35M
1D Range
3.55 3.76
52W Range
3.36 8.56

Valuation (TTM)

PE -2.22
PB 1.90
EV/EBITDA -1.18

Valuation (NTM)

Forward PE 2.66
Forward PEG 0.16
Price Target $22.00
Loading financial charts...

Profile

Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyp...

Sector Healthcare
Industry Biotechnology
Employees 21
IPO Date Jul 12, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Nov 18, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$22.00
Upside
+494.59%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.